Drug application
TRIPROLIDINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE AND CODEINE PHOSPHATE (CODEINE PHOSPHATE, PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE HYDROCHLORIDE)
Drugs@FDA ANDA 088833 · WOCKHARDT
Key facts
| Drug name | TRIPROLIDINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE AND CODEINE PHOSPHATE |
|---|---|
| Active ingredients | CODEINE PHOSPHATE, PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 088833 |
| Company | WOCKHARDT |
| Dosage forms | SYRUP, ORAL |
| Strength | 10MG/5ML;30MG/5ML;1.25MG/5ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Nov 16, 1984 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.